BiotechTube

solifenacin

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Stress Urinary Incontinence

Conditions

Stress Urinary Incontinence, Urgency Urinary Incontinence

Trial Timeline

Jun 1, 2011 → Jun 1, 2014

NCT ID
NCT01505439

About solifenacin

solifenacin is a approved stage product being developed by Astellas Pharma for Stress Urinary Incontinence. The current trial status is completed. This product is registered under clinical trial identifier NCT01505439. Target conditions include Stress Urinary Incontinence, Urgency Urinary Incontinence.

What happened to similar drugs?

7 of 20 similar drugs in Stress Urinary Incontinence were approved

Approved (7) Terminated (1) Active (13)
✅duloxetine HClEli LillyApproved
✅Duloxetine hydrochloride + placeboEli LillyApproved
✅Minocycline + PlaceboJohnson & JohnsonApproved
✅Placebo + sertralineJohnson & JohnsonApproved
✅Adjunctive asenapineMerckApproved
✅ZiprasidonePfizerApproved
✅Tramadol + PlaceboBrain BiotechApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (13)

NCT IDPhaseStatus
NCT02087098Pre-clinicalCompleted
NCT01642277Phase 2Completed
NCT01559389ApprovedCompleted
NCT01314781ApprovedCompleted
NCT01799902Pre-clinicalCompleted
NCT01505439ApprovedCompleted
NCT01318837ApprovedCompleted
NCT02667470ApprovedCompleted
NCT01122563Pre-clinicalCompleted
NCT00985387Pre-clinicalCompleted
NCT00979472ApprovedCompleted
NCT00884104ApprovedCompleted
NCT00852696Pre-clinicalTerminated

Competing Products

20 competing products in Stress Urinary Incontinence

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
35
agenT-797MiNK TherapeuticsPhase 1
19
Thermal stress and performance without a pre-cooling protocolPetros PharmaceuticalsPre-clinical
16
SivelestatEli LillyPhase 1/2
32
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine hydrochlorideEli LillyPhase 3
36
DuloxetineEli LillyPhase 3
40
duloxetine + PlaceboEli LillyPhase 2
35
Exenatide + InsulinEli LillyPhase 2/3
38
DuloxetineEli LillyPhase 3
40
duloxetine HClEli LillyApproved
43
Orforglipron + PlaceboEli LillyPhase 3
47
Duloxetine hydrochloride + placeboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine Hydrochloride + placeboEli LillyPhase 3
40